In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and publishe ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain.Journavx received FDA ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...

First Pediatric Guideline ... Advanced Pain Management Using AI for Drug Discovery Oct. 4, 2024 — An estimated one in five Americans live with chronic pain and current treatment options leave ...

GPs should routinely ask all patients who may be at risk of gambling-related harms about their habits, and guide affected patients to treatment services, according to a first-ever clinical guideline ...

The following is a summary of “Global Delphi consensus on treatment goals for generalised pustular psoriasis,” published in the January 2025 issue of Dermatology by Barker et al. Generalized pustular ...

Engaging patients in discussions about different phosphate binders and their unique characteristics is key to improving adherence and satisfaction. New therapies that reduce pill size or burden while ...